OBJECTIVE: An association between obesity and asthma symptoms has been reported in the literature, but such a relationship is inconsistent if atopic status or bronchial hyper responsiveness (BHR) is considered. The objective was to assess the association between obesity and asthma symptoms or BHR in adults. METHODS: A study was carried out in 1232 people born between 1974 and 1978 in Chile. The participants completed the European Community Health Survey questionnaire, were skin tested and subject to a BHR challenge to methacholine. MEASUREMENTS: Weight, height and waist circumference were measured and body mass index (BMI) was calculated. RESULTS: There was a positive association between wheeze and breathlessness following exercise and BMI (both with an OR 1.03, 95% CI 1.00-1.06), the associations with wheeze tended to disappear in women who did react at least to one allergen, and persisted in those who did not react to any allergens. BMI was negatively associated with BHR (OR 0.93, 95% CI 0.89-0.97). Waist circumference was not associated with asthma symptoms and it was negatively associated with BHR. CONCLUSION: Although there was an association between BMI and asthma symptoms, there were weaknesses in the evidence because waist circumference, a more direct measure of obesity than BMI, was not associated with asthma symptoms, and BMI and waist circumference were negatively associated with BHR.
Introduction
Studies carried out in developed countries have reported a link between obesity and asthma. 1, 2 Many of these countries have witnessed a rise in the prevalence of both pathologies. [3] [4] [5] In spite of numerous studies in the subject, there are still doubts as to the nature of the association between obesity and asthma. A study in Australia found an association between body mass index (BMI) and reported symptoms, but not with bronchial hyper responsiveness (BHR) or among those with asthma symptoms and atopic status. They concluded that the increased symptoms were not caused by asthma. 6 In the European Community Respiratory Health Survey (ECRHS), the combined result of participating centres showed an association between obesity and those with breathlessness and wheeze, albeit showing a degree of heterogeneity between countries. 7 A separate report from the same study showed an association between BMI and BHR slope, but the association was statistically significant only in men 8 and the association between BMI and BHR was small.
There is no information on the trends of asthma in Latin America, but the prevalence of asthma symptoms in children and adolescents in Chile has been shown to be high. 9 Obesity has markedly increased in Latin America. 10, 11 In
Chile, approximately 25% of the women have a BMI above 30 kg/m 2 . 12 Most of the reports on the association between asthma and obesity are based on studies carried out in developed countries. We carried out a study on predisposing factors of asthma in young adults in a semirural area of Chile. In this paper we assess the association between obesity and asthma symptoms and BHR.
Materials and methods
This was a cross-sectional analysis of 1,232 men and women selected from a sampling frame of 3096 babies born between 1974 and 1978 in the hospital of Limache, a small city of 50 000 inhabitants approximately 120 km from Santiago in Chile. Limache is an agricultural area and many of its products are exported. Its level of poverty is slightly above the national mean. 13 If a person could not be found, could not participate because of severe disability or custodial sentence, or did not give consent to participate, a replacement was obtained by random selection. Men were more reluctant to participate, especially those who were working in the fields and who also needed permission from their foreman or manager. The participants completed a Spanish version of the ECHRS questionnaire in an interview. BHR to methacholine was assessed using the tidal breathing method in a hospital environment. Increasing concentrations of 0.5, 1.00, 4.00, 8.00 and 16 mg/ml were used with a Hudson nebuliser at a flow rate of 0.13 l/min over a 2-min period. Forced expiratory volume in a second (FEV 1) was measured at baseline and 2 min after each tidal breathing period using a Vitalograph 2121 and software Spirotrac IV following the ATS norms. 14 The best FEV 1 out of five attempts was selected as baseline and the test was stopped when either a 20% fall in FEV 1 was achieved or the final concentration of 16 mg/ml was reached. 15 Participants were asked not to smoke for at least 1 h before the assessment and not to use asthma relievers or preventives during the period of 6 h before the test. Those with a history of epilepsy, current pregnancy or breastfeeding were excluded from the assessment. Skin reaction to the following common eight allergens prepared by Allergy Therapeutic s were carried out: Dermatophagoides Pteronyssinus, Alternaria Alternata, cat fur, dog hair, cockroach, and blends of grass pollens, trees, and weeds and shrubs. A participant with a reaction of 3 mm or over to any of the eight allergens was considered to be atopic in this analysis.
Height was measured to the last completed millimetre in bare-footed participants and weight was assessed using beam weighing scales. We also assessed waist circumference using a flexible tape at the level of the navel with the patient standing.
Supervised university nurses especially trained for this study undertook all the assessments including the administered questionnaire. This study received ethical approval from the Ethics Committee of the Medical Faculty of the University of Chile and participants were asked to sign a consent form after reading and listening to explanatory notes about the study.
We included in the analysis the following asthma symptoms: wheeze in the previous 12 months, breathlessness following intense physical exercise, and the combined symptoms of wheeze and waking up with breathlessness.
BMI (weight/height ) and severe obesity (35 kg/m 2 or over). We also carried out analysis using waist circumference as an indicator of central obesity.
Multiple logistic regressions were carried out using asthma symptoms or BHR as dependent variables. We assessed wheeze and breathlessness following exercise in the last 12 months by atopic status. The other variables were not analysed by atopic status, as their prevalence was lower in comparison to the other two symptoms. BMI or waist circumference were used as the main independent variables as explained above. Adjustments were made for number of siblings, smoking and schooling and, if appropriate, gender. Significant differences between normal BMI category and all the other groups. ANOVA and Scheffé analysis were used to compare means between groups, and to look for imbalances between them.
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Results Table 1 shows the characteristics of the participants in the study by BMI categories. Only 5.0% had a BMI below 20 kg/ m 2 , 14.1% were moderately or severely obese and 35.2% were overweight. Both obesity and underweight were more prevalent in women (19.9 and 5.8% respectively) than in men (8.8 and 4.0% respectively). Number of years of fulltime education was negatively associated with BMI status. There was an increasing trend of asthma symptoms, but a decreasing trend of prevalence of BHR with increasing BMI. The best FEV 1 was higher in the normal category of BMI in comparison to the other groups, but without significant differences between them. Although there was not a statistically significant heterogeneity between groups, there were more smokers in the severely obese group and fewer smokers in the underweight group. Obese men and women were taller than subjects in other categories, but these differences were not statistically significant. Waist circumference was strongly correlated with BMI (Pearson' correlation ¼ 0.908, Po0.0001).
There was a significant positive association between BMI and wheeze, but only in women (Table 2 ). This association was significant for the nonatopic group (OR: 1.04, CI 1.01-1.08) but not for the atopic category (OR: 0.98, CI 0.93-1.04, not shown). There was also an association between breathlessness following exercise and increasing BMI, but only significant in women. The association between BMI and wheeze and breathlessness following exercise together was not statistically significant. There was a negative association between BMI and BHR, especially in women. The ORs changed only marginally after adjustment. There was an association between atopy and BMI, but only in men.
We did not find an association between waist circumference and asthma symptoms or atopy in men or females. Adjusted by smoking, number of siblings and years of school. Adjusted by smoking, years of school and number of siblings. Adjusted by sex, smoking, years of school and number of siblings.
As for BMI, waist circumference was borderline nonsignificantly associated with asthma diagnosed by a physician. However, there was a negative association between waist circumference and BHR in women (Table 3) . There were statistically insignificant associations between BMI categories and asthma symptoms or asthma diagnosed by a physician (Table 4) . Underweight subjects had less asthma symptoms, but the conventional 5% significant level was only reached with wheeze. Obese subjects had significantly lower ORs of BHR. Interaction between gender and obesity status on asthma outcomes were not statistically significant.
Discussion
In this study we found a high prevalence of obesity, especially in women demonstrating that obesity is also a problem in some of the middle industrialised countries. In agreement with most studies, 1, 2, [6] [7] [8] 16, 17 there was a positive association between BMI and asthma symptoms. However, waist circumference was not associated with asthma symptoms and both BMI and waist circumference were negatively associated with BHR. There was very little evidence that the association between obesity and asthma symptoms was related to atopic status. The strengths of this study are that two measures for assessing fatness, BMI and waist circumference were used unlike other studies; asthma status was assessed using the standardised ECRHS questionnaire, 7 atopic status was assessed as standardised in the first ECRHS survey and BHR challenge to methacholine was assessed by the tidal breathing method using the standardised procedure described by the ATS. 14, 15 We used the tidal breathing method because our subjects follow the instructions of this method better than methods based on the dosimeter, and it is the method of choice in specialists' centres in Chile. The two methods seem to be equivalent. 18 All participants had complete data and we needed to eliminate only one subject from the analyses. There were proportionally more women than men in the study as it was more difficult to find men and to obtain their consent for the study. Although this was a large survey, the analysis based on BMI or waist circumference categories and atopic status had low statistical power. Our study is consistent with the large number of reports that have found an association between BMI and asthma symptoms in women but not in men. 2 It is unclear whether this difference between genders is genuine or due to a lower statistical power to detect an association in men. In the ECRHS study there was not gender interaction for most asthma symptoms, but a significant interaction at 5% level for an attack of asthma in the last 12 months. 7 In our study interactions between obesity status and gender on asthma outcomes were statistically insignificant. As obesity is not only highly prevalent in developed countries, but also in emerging countries, it is of public health relevance to elucidate whether the association between BMI and asthma is causal. A first threat to a genuine causal relationship is the misclassification of asthma symptoms. The low agreement between recognition of asthma symptoms before and after a videotape showing the characteristics of asthma symptoms, especially in nonEnglish speaking countries, may suggest that participants recognise as asthma symptoms a variety of symptoms mimicking asthma symptoms, or, symptoms that are part of another pathology. 19 However lack of specificity per se is an inappropriate criterion for explaining a noncausal association between BMI and asthma symptoms. If anything, the fact that the association is consistent in many studies despite a high degree of misclassification would be in support of a causal relation between BMI and asthma. Bias reporting would be an important requirement for supporting a spurious association. There are two possible ways in which bias reporting may arise between BMI and asthma symptoms: firstly, those reporting asthma symptoms are more likely to have anxiety and somatise, or to have depression 20, 21 and these symptoms are more frequent in obese people [22] [23] [24] [25] and, secondly, obesity may be a risk factor for dyspnoea, rather than airflow obstruction. 26 There is ample evidence that anxiety and depression are associated with obesity. [22] [23] [24] [25] Binge eating is a mechanism for gaining weight and also may be an expression of anxiety. Thus, obese participants may overreport asthma symptoms because of psychological symptoms. Asthma symptoms such as wheeze are frequently included in somatisation scales. Obese subjects tend to have dyspnoea and panting with exercise, and moderate dyspnoea at rest. 26 Breathlessness can be a characteristic of asthma, but might also be a component of a nonrespiratory condition in those with excess fatness. In the report of Sin and co-workers, obese participants in the NHANES study had an excess of asthma symptoms and bronchodilator use, but had the lowest prevalence of airflow obstruction. 27 Gastrooesophageal reflux is associated with BMI and asthma, 28, 29 but there is insufficient information supporting this association in community studies. In contrast to other studies, 30, 31 we failed to find an association between waist circumference and asthma symptoms. The other two studies were consistent to show that BMI and waist circumference were associated with asthma symptoms, but in one of these studies the association was found only in women. 30 Waist circumference is a good measure for assessing central fatness in adults. 32 Our results are counterintuitive in so far as it would suggest that central fatness assessed by waist circumference would be less related to asthma symptoms than the general distribution of fatness assessed by BMI. This issue should be further explored. A finding in our study that would not support a causal link between obesity and asthma was the consistent negative association between BHR with BMI, and BHR and waist circumference in women. Our findings are consistent with the results reported by Schachter and co-workers. 6, 33 The ECRHS study reported a positive association between BMI and BHR, but the association was significant in men and not
Obesity and asthma P Bustos et al women. 8 As the interaction of gender and BMI on BHR was not statistically significant, their main conclusion was based on the results of the total sample. However, there are two elements in their summary findings that need further explanation: firstly, that the significant association between BMI and BHR was found only in men whereas the association between obesity and asthma symptoms was stronger in females. Secondly, that there was a borderline insignificant level of heterogeneity in the association between BMI and BHR in men. In our study, there was a mild association between BMI and atopy only in men, different to the findings in children or adolescents in which BMI was a significant predictor of atopy in girls. 33, 34 We explored whether there was a difference between those with asthma symptoms according to their atopic status. We elaborated that if the association were restricted to those in the group with the most specific symptoms of asthma, that is, atopics, this would be in support of a causal link between obesity and asthma. Schachter and co-workers were able to show such an association mainly in nonatopics, 6 thus giving support to a less specific relation between asthma and obesity, but we were unable to find a clear response. Although Rothman has expressed scepticism on the use of checklists to assess causality as proposed by Hill, 35, 36 it is a convenient manner of summarising the evidence from our paper. The positive association between BMI and asthma symptoms was only moderate, but exhibited a biologic gradient. However, the associations of obesity and asthma were inconsistent both according to type of assessment of obesity, BMI or waist circumference, and type of asthma outcome used, asthma symptoms or positive BHR. We cannot contribute to temporality of events because the study design was cross-sectional. Thus, in conclusion, our study confirms the known positive association between BMI and asthma symptoms, but our findings suggest that this association may not be causal because BHR was negatively related to BMI and waist circumference and asthma symptoms were unrelated to waist circumference.
